Literature DB >> 27613537

Guanosine prevents nitroxidative stress and recovers mitochondrial membrane potential disruption in hippocampal slices subjected to oxygen/glucose deprivation.

Daniel T Thomaz1, Tharine A Dal-Cim2, Wagner C Martins2, Maurício Peña Cunha1, Débora Lanznaster2, Andreza F de Bem3,1,2, Carla I Tasca4,5,6.   

Abstract

Guanosine, the endogenous guanine nucleoside, prevents cellular death induced by ischemic events and is a promising neuroprotective agent. During an ischemic event, nitric oxide has been reported to either cause or prevent cell death. Our aim was to evaluate the neuroprotective effects of guanosine against oxidative damage in hippocampal slices subjected to an in vitro ischemia model, the oxygen/glucose deprivation (OGD) protocol. We also assessed the participation of nitric oxide synthase (NOS) enzymes activity on the neuroprotection promoted by guanosine. Here, we showed that guanosine prevented the increase in ROS, nitric oxide, and peroxynitrite production induced by OGD. Moreover, guanosine prevented the loss of mitochondrial membrane potential in hippocampal slices subjected to OGD. Guanosine did not present an antioxidant effect per se. The protective effects of guanosine were mimicked by inhibition of neuronal NOS, but not of inducible NOS. The neuroprotective effect of guanosine may involve activation of cellular mechanisms that prevent the increase in nitric oxide production, possibly via neuronal NOS.

Entities:  

Keywords:  Guanosine; Hippocampal slices; Nitric oxide synthase; Nitroxidative stress; Oxygen/glucose deprivation; Peroxynitrite

Mesh:

Substances:

Year:  2016        PMID: 27613537      PMCID: PMC5124011          DOI: 10.1007/s11302-016-9534-3

Source DB:  PubMed          Journal:  Purinergic Signal        ISSN: 1573-9538            Impact factor:   3.765


  53 in total

1.  Neuroprotective effect of GMP in hippocampal slices submitted to an in vitro model of ischemia.

Authors:  Ivaldo J L Oliveira; Simone Molz; Diogo O Souza; Carla I Tasca
Journal:  Cell Mol Neurobiol       Date:  2002-06       Impact factor: 5.046

2.  Membrane potential can be determined in individual cells from the nernstian distribution of cationic dyes.

Authors:  B Ehrenberg; V Montana; M D Wei; J P Wuskell; L M Loew
Journal:  Biophys J       Date:  1988-05       Impact factor: 4.033

3.  Guanosine protects C6 astroglial cells against azide-induced oxidative damage: a putative role of heme oxygenase 1.

Authors:  André Quincozes-Santos; Larissa Daniele Bobermin; Débora Guerini Souza; Bruna Bellaver; Carlos-Alberto Gonçalves; Diogo Onofre Souza
Journal:  J Neurochem       Date:  2014-03-24       Impact factor: 5.372

4.  Effect of orally administered guanosine on seizures and death induced by glutamatergic agents.

Authors:  D R Lara; A P Schmidt; M E Frizzo; J S Burgos; G Ramírez; D O Souza
Journal:  Brain Res       Date:  2001-09-07       Impact factor: 3.252

5.  Extracellular guanosine regulates extracellular adenosine levels.

Authors:  Edwin K Jackson; Dongmei Cheng; Travis C Jackson; Jonathan D Verrier; Delbert G Gillespie
Journal:  Am J Physiol Cell Physiol       Date:  2012-12-12       Impact factor: 4.249

6.  Guanosine controls inflammatory pathways to afford neuroprotection of hippocampal slices under oxygen and glucose deprivation conditions.

Authors:  Tharine Dal-Cim; Fabiana K Ludka; Wagner C Martins; Charlise Reginato; Esther Parada; Javier Egea; Manuela G López; Carla I Tasca
Journal:  J Neurochem       Date:  2013-06-17       Impact factor: 5.372

Review 7.  Targeting eNOS for stroke protection.

Authors:  Matthias Endres; Ulrich Laufs; James K Liao; Michael A Moskowitz
Journal:  Trends Neurosci       Date:  2004-05       Impact factor: 13.837

8.  Effects of cerebral ischemia in mice deficient in neuronal nitric oxide synthase.

Authors:  Z Huang; P L Huang; N Panahian; T Dalkara; M C Fishman; M A Moskowitz
Journal:  Science       Date:  1994-09-23       Impact factor: 47.728

9.  The potential therapeutic effect of guanosine after cortical focal ischemia in rats.

Authors:  Gisele Hansel; Denise Barbosa Ramos; Camila Aguilar Delgado; Débora Guerini Souza; Roberto Farina Almeida; Luis Valmor Portela; André Quincozes-Santos; Diogo Onofre Souza
Journal:  PLoS One       Date:  2014-02-28       Impact factor: 3.240

Review 10.  Guanosine: a Neuromodulator with Therapeutic Potential in Brain Disorders.

Authors:  Débora Lanznaster; Tharine Dal-Cim; Tetsadê C B Piermartiri; Carla I Tasca
Journal:  Aging Dis       Date:  2016-10-01       Impact factor: 6.745

View more
  15 in total

Review 1.  Neuroprotective Effects of Guanosine in Ischemic Stroke-Small Steps towards Effective Therapy.

Authors:  Karol Chojnowski; Mikolaj Opielka; Wojciech Nazar; Przemyslaw Kowianski; Ryszard T Smolenski
Journal:  Int J Mol Sci       Date:  2021-06-27       Impact factor: 5.923

2.  Guanosine promotes cytotoxicity via adenosine receptors and induces apoptosis in temozolomide-treated A172 glioma cells.

Authors:  Karen A Oliveira; Tharine A Dal-Cim; Flávia G Lopes; Cláudia B Nedel; Carla Inês Tasca
Journal:  Purinergic Signal       Date:  2017-05-23       Impact factor: 3.765

3.  2',3'-cGMP exists in vivo and comprises a 2',3'-cGMP-guanosine pathway.

Authors:  Edwin K Jackson; Zaichuan Mi; Keri Janesko-Feldman; Travis C Jackson; Patrick M Kochanek
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2019-02-21       Impact factor: 3.619

Review 4.  Purine nucleoside phosphorylase as a target to treat age-associated lower urinary tract dysfunction.

Authors:  Lori A Birder; Edwin K Jackson
Journal:  Nat Rev Urol       Date:  2022-09-07       Impact factor: 16.430

5.  Guanosine prevents oxidative damage and glutamate uptake impairment induced by oxygen/glucose deprivation in cortical astrocyte cultures: involvement of A1 and A2A adenosine receptors and PI3K, MEK, and PKC pathways.

Authors:  Tharine Dal-Cim; Gabriela G Poluceno; Débora Lanznaster; Karen A de Oliveira; Claudia B Nedel; Carla I Tasca
Journal:  Purinergic Signal       Date:  2019-09-13       Impact factor: 3.765

6.  Guanosine ameliorates positive symptoms of schizophrenia via modulating 5-HT1A and 5-HT2A receptors.

Authors:  Yu Mao; Yao Xing; Jie Li; Dong Dong; Shoude Zhang; Zhenjiang Zhao; Jingli Xie; Rui Wang; Honglin Li
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

7.  Guanosine, a guanine-based nucleoside relaxed isolated corpus cavernosum from mice through cGMP accumulation.

Authors:  Aline de Souza Nicoletti; Gabriela Reolon Passos; Gabriela Maria Bertollotto; Caroline Honaiser Lescano; Mariana Gonçalves de Oliveira; Edson Antunes; Fabiola Zakia Mónica
Journal:  Purinergic Signal       Date:  2020-05-27       Impact factor: 3.765

8.  Guanosine Neuroprotective Action in Hippocampal Slices Subjected to Oxygen and Glucose Deprivation Restores ATP Levels, Lactate Release and Glutamate Uptake Impairment: Involvement of Nitric Oxide.

Authors:  Daniel Tonial Thomaz; Rafaela Rafognatto Andreguetti; Luisa Bandeira Binder; Débora da Luz Scheffer; Alisson Willms Corrêa; Fátima Regina Mena Barreto Silva; Carla Inês Tasca
Journal:  Neurochem Res       Date:  2020-07-14       Impact factor: 4.414

9.  Uncovering the Signaling Pathway behind Extracellular Guanine-Induced Activation of NO System: New Perspectives in Memory-Related Disorders.

Authors:  Mariachiara Zuccarini; Patricia Giuliani; Monica Frinchi; Giuseppa Mudò; Rosa Maria Serio; Natale Belluardo; Silvana Buccella; Marzia Carluccio; Daniele F Condorelli; Francesco Caciagli; Renata Ciccarelli; Patrizia Di Iorio
Journal:  Front Pharmacol       Date:  2018-02-21       Impact factor: 5.810

10.  Antiparkinsonian Efficacy of Guanosine in Rodent Models of Movement Disorder.

Authors:  Caio M Massari; Marc López-Cano; Fabiana Núñez; Víctor Fernández-Dueñas; Carla I Tasca; Francisco Ciruela
Journal:  Front Pharmacol       Date:  2017-10-04       Impact factor: 5.810

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.